1081 related articles for article (PubMed ID: 18491964)
1. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
2. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
3. Update on Clostridium difficile-induced colitis, Part 2.
Reinke CM; Messick CR
Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
[TBL] [Abstract][Full Text] [Related]
4. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
Musher DM; Aslam S; Logan N; Nallacheru S; Bhaila I; Borchert F; Hamill RJ
Clin Infect Dis; 2005 Jun; 40(11):1586-90. PubMed ID: 15889354
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
Lagrotteria D; Holmes S; Smieja M; Smaill F; Lee C
Clin Infect Dis; 2006 Sep; 43(5):547-52. PubMed ID: 16886144
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Pepin J
Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
[TBL] [Abstract][Full Text] [Related]
9. Past, present, and future therapies for Clostridium difficile-associated disease.
Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Huggan PJ; Murdoch DR
Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
[No Abstract] [Full Text] [Related]
11. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Bishara J; Wattad M; Paul M
Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
[No Abstract] [Full Text] [Related]
12. Vancomycin-induced elevation of liver enzyme levels.
Cadle RM; Mansouri MD; Darouiche RO
Ann Pharmacother; 2006 Jun; 40(6):1186-9. PubMed ID: 16720708
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: a prospective controlled study.
Lu SS; Schwartz JM; Simon DM; Brandt LJ
Am J Gastroenterol; 1994 Aug; 89(8):1226-9. PubMed ID: 8053439
[TBL] [Abstract][Full Text] [Related]
14. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
Bakken JS
Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile-associated disease treatment response depends on definition of cure.
Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
[No Abstract] [Full Text] [Related]
16. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
17. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
[TBL] [Abstract][Full Text] [Related]
19. [Feces culture successful therapy in Clostridium difficile diarrhea].
Jorup-Rönström C; Håkanson A; Persson AK; Midtvedt T; Norin E
Lakartidningen; 2006 Nov 15-21; 103(46):3603-5. PubMed ID: 17153868
[No Abstract] [Full Text] [Related]
20. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
Kuijper EJ; Wilcox MH
Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
